For decades, the script of cancer immunology seemed straightforward. Tumors evade destruction by hijacking immune checkpoints—inhibitory receptors on T cells...
In a sweeping analysis of over 2.4 million cancer cases across the United States, researchers have uncovered a stark and...
A rogue population of immune cells, long overlooked in the complex landscape of the human gut, has been unmasked as...
Acute lymphoblastic leukemia (ALL), a malignancy of the lymphoid progenitor cells, has long been a focus of intense biomedical research...
The small intestine is a marvel of biological engineering, tasked with the immense responsibility of absorbing a vast array of...
In the relentless pursuit of personalized cancer treatment, a groundbreaking artificial intelligence (AI) model named COMPASS is setting a new...
The Apelin–APLNR Signaling Axis: A Novel Guardian of Lung Health and Inflammation In recent years, the Apelin–APLNR pathway has emerged...
On July 1, 2026, a significant advancement was announced in the realm of clinical cancer research with the appointment of...
In a groundbreaking study published recently, researchers unveiled a meticulous validation of the positron emission tomography (PET) tracer ^18F-THK5351, a...
In a groundbreaking advancement for kidney cancer therapeutics, researchers at the Dana-Farber Cancer Institute have pioneered the first-in-patient clinical trial...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine